Abstract
The basic problem faced by the pharmaceutical industry is to provide efficacious products which are safe for use by the intended consumer. Literally hundreds of new products and formulations are developed each year which must be evaluated for all aspects of potential toxicity. The need for simple, rapid and reliable test methods is obvious. The potential of in vitro tests to meet these needs is equally obvious. The advantages of in vitro tests over conventional whole animal tests include significant reductions in cost, time and physical resources. In addition, in vitro tests have the advantage of addressing the concerns of animal welfare advocates by reducing and/or eliminating the utilization of live animals in toxicity tests.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Frazier, J.M. (1986). In Vitro Models for Acute Toxicity Testing. In: Schuppan, D., Dayan, A.D., Charlesworth, F.A. (eds) The Contribution of Acute Toxicity Testing to the Evaluation of Pharmaceuticals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70390-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-70390-4_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70392-8
Online ISBN: 978-3-642-70390-4
eBook Packages: Springer Book Archive